tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Rhythm Pharmaceuticals Announces Stock Offering Agreement
PremiumCompany AnnouncementsRhythm Pharmaceuticals Announces Stock Offering Agreement
10d ago
Positive Outlook for Rhythm Pharmaceuticals Driven by Promising Phase 2 Results and Strategic MC4R Franchise Management
Premium
Ratings
Positive Outlook for Rhythm Pharmaceuticals Driven by Promising Phase 2 Results and Strategic MC4R Franchise Management
10d ago
Citiznes JMP biotech analysts hold an analyst/industrry conference call
Premium
The Fly
Citiznes JMP biotech analysts hold an analyst/industrry conference call
10d ago
Rhythm Pharmaceuticals price target raised to $129 from $91 at Wells Fargo
PremiumThe FlyRhythm Pharmaceuticals price target raised to $129 from $91 at Wells Fargo
11d ago
Rhythm Pharmaceuticals price target raised to $95 from $73 at BofA
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $95 from $73 at BofA
11d ago
Rhythm Pharmaceuticals resumed with a Buy at Goldman Sachs
Premium
The Fly
Rhythm Pharmaceuticals resumed with a Buy at Goldman Sachs
11d ago
Rhythm Pharmaceuticals price target raised to $95 from $73 at BofA
PremiumThe FlyRhythm Pharmaceuticals price target raised to $95 from $73 at BofA
11d ago
Rhythm Pharmaceuticals price target raised to $95 from $80 at Morgan Stanley
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $95 from $80 at Morgan Stanley
11d ago
Rhythm Pharmaceuticals price target raised to $123 from $94 at Stifel
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $123 from $94 at Stifel
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100